MichaelGeorgeWilkersonMD
Dermatology • League City, TXMichael G. Wilkerson, M.D., M.S., FAAD Professor and Chair Department of Dermatology John Sealy Distinguished Chair in Dermatology University of Texas Medical Branch 301 University Blvd. Galveston, Texas 77555
Dr. Wilkerson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Dermatology 2660 Gulf Freeway South
Entrance A Suite 14
League City, TX 77573Phone+1 281-534-3376Fax+1 281-337-7035
Summary
- Dr. Michael Wilkerson is Professor and Chair of the Department of Dermatology at the University of Texas Medical Branch in Galveston, Texas. He received his medical degree from University of Texas Medical School at Houston.and has been in practice 33 years. He is experienced in atopic dermatitis, psoriasis, pemphigus vulgaris, pemphigoid diseases, malignant melanoma, and non-melanoma skin cancer.
Education & Training
Virginia Commonwealth University Health SystemResidency, Dermatology, 1985 - 1988- Virginia Commonwealth University Health SystemInternship, Internal Medicine, 1984 - 1985
McGovern Medical School at UTHealthClass of 1984
Certifications & Licensure
TX State Medical License 1985 - 2026
OK State Medical License 1988 - 2025- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- President Texas Dermatological Society
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow (FAAD) American Academy of Dermatology
- Join now to see all
Publications & Presentations
PubMed
- 13 citationsKeloid Scars: An Updated Review of Combination TherapiesNicholas J Thornton, Benjamin A. Garcia, Paige Hoyer, Michael G. Wilkerson
Cureus. 2021-01-30 - 1 citationsBenzoyl peroxide for acne treatment is not associated with an increased risk of malignancy: A retrospective cohort study.David Garate, Christopher J Thang, Jenny Lai, George Golovko, Michael G Wilkerson
Journal of the American Academy of Dermatology. 2024-11-01 - 9 citationsExacerbation of bullous pemphigoid after hand, foot, and mouth disease treated with rituximab.Alfreda F. Batts, Sheila Z. Jalalat, Lindsey Hunter-Ellul, Michael G. Wilkerson
JAAD Case Reports. 2016-01-01
Press Mentions
A Study Associates the Use of Hydroquinone with the Risk of Skin Cancer -News ForestAugust 26th, 2022
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
